For almost 4 a long time, most cancers researchers confronted a persistent drawback. They knew {that a} mutation in a gene known as KRAS was driving a few of the deadliest tumors for pancreatic, lung, and colorectal cancers, however each try to construct a drug that would block it got here up brief.
